Prognostic values of HE4 expression in patients with cancer: a meta-analysis

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• AbeSKawaiKIshiharaSPrognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resectionJ Surg Res2016205238439227664887
   PubMed Web of Science ®Google Scholar
• JiangHTangEXuDDevelopment and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancerOncotarget2017818298572986428415740
   PubMedGoogle Scholar
• SpeeckaertMMSpeeckaertRDelangheJRHuman epididymis protein 4 in cancer diagnostics: a promising and reliable tumor markerAdv Clin Chem20135912123461131
   PubMed Web of Science ®Google Scholar
• KarlsenNSKarlsenMAHøgdallCKHøgdallEVHE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic reviewCancer Epidemiol Biomarkers Prev201423112285229525169975
   PubMed Web of Science ®Google Scholar
• ChangXYeXDongLHuman epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinomaInt J Gynecol Cancer201121585285821633297
   PubMed Web of Science ®Google Scholar
• StiekemaALokCKorseCMSerum HE4 is correlated to prognostic factors and survival in patients with endometrial cancerVirchows Arch2017470665566428401338
   PubMed Web of Science ®Google Scholar
• Aarenstrup KarlsenMHøgdallCNedergaardLHE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancerAPMIS2016124121038104527859687
   PubMed Web of Science ®Google Scholar
• LamyPJPlassotCPujolJLSerum HE4: An independent prognostic factor in non-small cell lung cancerPLoS One2015106e012883626030627
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
   PubMed Web of Science ®Google Scholar
• OrsariaMLonderoAPMarzinottoSdi LoretoCMarchesoniDMariuzziLPlacental type alkaline phosphatase tissue expression in ovarian serous carcinomaCancer Biomark201617447948627802199
   PubMed Web of Science ®Google Scholar
• LanWGHaoYZXuDHWangPZhouYLMaLBSerum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancerClin Transl Oncol201618437538026329292
   PubMed Web of Science ®Google Scholar
• DengLGaoYLiXExpression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinomaJ Exp Clin Cancer Res2015349626362938
   PubMed Web of Science ®Google Scholar
• LiXGaoYTanMExpression of HE4 in Endometrial cancer and its clinical significanceBiomed Res Int20152015437468826539494
   PubMed Web of Science ®Google Scholar
• LeeYCHuangCCLinDYChangWCLeeKHOverexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevancePeerJ20153e138626587348
   PubMed Web of Science ®Google Scholar
• GuoYDWangJHLuHThe human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancerTumour Biol20153642457246425432133
   PubMed Web of Science ®Google Scholar
• LouEJohnsonMSimaCSerum biomarkers for assessing histology and outcomes in patients with metastatic lung cancerCancer Biomark201414420721424934363
   PubMed Web of Science ®Google Scholar
• JiangYWangCLvBMaGWangLExpression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancerInt J Clin Exp Med20147125568557225664073
   PubMed Web of Science ®Google Scholar
• BrennanDJHackethalAMetcalfAMANECS GroupSerum HE4 as a prognostic marker in endometrial cancer--a population based studyGynecol Oncol2014132115916524211402
   PubMed Web of Science ®Google Scholar
• ZhangYZhengYJiangLZhaoZLiuWThe prognostic value of serum HE4 in lung cancerChin J Radiol Med Prot2014346423426
   Google Scholar
• BraicuEIChekerovRRichterRHE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapseAnn Surg Oncol201421395596224217786
   PubMed Web of Science ®Google Scholar
• ZhengHGaoYNGaoWJGaoMYanXExpression of serum human epididymis protein 4 in epithelial ovarian cancer and its correlation with prognosisZhonghua Zhong Liu Za Zhi201335644544924119905
   PubMedGoogle Scholar
• LiuWYangJChiPDEvaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosisInt J Tuberc Lung Dis201317101346135324025389
   PubMed Web of Science ®Google Scholar
• ZanottiLBignottiECalzaSHuman epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcomeClin Chem Lab Med201250122189219823096757
   PubMed Web of Science ®Google Scholar
• YamashitaSTokuishiKMorogaTSerum level of HE4 is closely associated with pulmonary adenocarcinoma progressionTumour Biol20123362365237023001907
   PubMedGoogle Scholar
• TrudelDTêtuBGrégoireJHuman epididymis protein 4 (HE4) and ovarian cancer prognosisGynecol Oncol2012127351151522967799
   PubMed Web of Science ®Google Scholar
• Mutz-DehbalaieIEgleDFesslerSHE4 is an independent prognostic marker in endometrial cancer patientsGynecol Oncol2012126218619122525819
   PubMed Web of Science ®Google Scholar
• KongSYHanMHYooHJSerum HE4 level is an independent prognostic factor in epithelial ovarian cancerAnn Surg Oncol20121951707171221833668
   PubMed Web of Science ®Google Scholar
• KalapotharakosGAsciuttoCHenicECasslénBBorgfeldtCHigh preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancerJ Ovarian Res2012512022909379
   PubMed Web of Science ®Google Scholar
• HuSWangMGaoJQiJThe clinical value of serum HE4 for prognosis evaluation in patients with ovarian cancerChina Cancer2012218638640
   Google Scholar
• SteffensenKDWaldstrømMBrandslundIJakobsenAPrognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patientsInt J Gynecol Cancer20112161040104721738039
   PubMed Web of Science ®Google Scholar
• YamashitaSTokuishiKHashimotoTPrognostic significance of HE4 expression in pulmonary adenocarcinomaTumour Biol201132226527120953751
   PubMed Web of Science ®Google Scholar
• PaekJLeeSHYimGWPrognostic significance of human epididymis protein 4 in epithelial ovarian cancerEur J Obstet Gynecol Reprod Biol2011158233834221683503
   PubMed Web of Science ®Google Scholar
• HanJJYuMHoustonNSteinbergSMKohnECProgranulin is a potential prognostic biomarker in advanced epithelial ovarian cancersGynecol Oncol2011120151020950846
   PubMed Web of Science ®Google Scholar
• BignottiERagnoliMZanottiLDiagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsBr J Cancer201110491418142521468050
   PubMed Web of Science ®Google Scholar
• BandieraERomaniCSpecchiaCSerum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer managementCancer Epidemiol Biomarkers Prev201120122496250622028406
   PubMed Web of Science ®Google Scholar
• KirchhoffCHabbenIIvellRKrullNA major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitorsBiol Reprod19914523503571686187
   PubMed Web of Science ®Google Scholar
• BingleLSingletonVBingleCDThe putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoformsOncogene200221172768277311965550
   PubMed Web of Science ®Google Scholar
• ClaussALiljaHLundwallAA locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic proteinBiochem J2002368Pt 123324212206714
   PubMed Web of Science ®Google Scholar
• GaoLChengHYDongLThe role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasisJ Int Med Res20113951645166022117965
   PubMed Web of Science ®Google Scholar
• KongXChangXChengHMaRYeXCuiHHuman epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathwaysInt J Gynecol Cancer201424342743624557433
   PubMed Web of Science ®Google Scholar
• Chudecka-GłazARzepka-GórskaIWojciechowskaIHuman epididymal protein 4 (HE4) is a novel biomarker and a promising prognostic factor in ovarian cancer patientsEur J Gynaecol Oncol201233438239023091895
   PubMed Web of Science ®Google Scholar
• LeeSChoiSLeeYChungDHongSParkNRole of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancerJ Obstet Gynaecol Res201743122022727862665
   PubMed Web of Science ®Google Scholar
• ZhongHQianYFangSYangLLiLGuWHE4 expression in lung cancer, a meta-analysisClinica Chimica Acta2017470109114
   PubMed Web of Science ®Google Scholar